DE60031963D1 - Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe - Google Patents

Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe

Info

Publication number
DE60031963D1
DE60031963D1 DE60031963T DE60031963T DE60031963D1 DE 60031963 D1 DE60031963 D1 DE 60031963D1 DE 60031963 T DE60031963 T DE 60031963T DE 60031963 T DE60031963 T DE 60031963T DE 60031963 D1 DE60031963 D1 DE 60031963D1
Authority
DE
Germany
Prior art keywords
superantigenactivity
msrv
evidence
induced
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60031963T
Other languages
English (en)
Other versions
DE60031963T2 (de
Inventor
Herve Perron
Monique Lafont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9903622A external-priority patent/FR2791139B1/fr
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of DE60031963D1 publication Critical patent/DE60031963D1/de
Application granted granted Critical
Publication of DE60031963T2 publication Critical patent/DE60031963T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60031963T 1999-03-19 2000-03-20 Verfahren zum Nachweis von Multipler Sklerose oder einer Prädisposition für die Entwicklung von Multipler Sklerose in einer biologischen Probe Expired - Lifetime DE60031963T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9903622A FR2791139B1 (fr) 1999-03-19 1999-03-19 Procede de detection d'une activite superantigenique dans un echantillon biologique
FR9903622 1999-03-19
FR9913755A FR2791140B1 (fr) 1999-03-19 1999-10-28 Procede de detection d'une activite superantigenique dans un echantillon et composition therapeutique ou prophylactique
FR9913755 1999-10-28
PCT/FR2000/000691 WO2000057185A1 (fr) 1999-03-19 2000-03-20 Detection d'une activite superantigenique dans un echantillon biologique

Publications (2)

Publication Number Publication Date
DE60031963D1 true DE60031963D1 (de) 2007-01-04
DE60031963T2 DE60031963T2 (de) 2007-06-14

Family

ID=26234877

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031963T Expired - Lifetime DE60031963T2 (de) 1999-03-19 2000-03-20 Verfahren zum Nachweis von Multipler Sklerose oder einer Prädisposition für die Entwicklung von Multipler Sklerose in einer biologischen Probe

Country Status (10)

Country Link
US (1) US20060088820A1 (de)
EP (1) EP1163522B1 (de)
JP (1) JP2002539804A (de)
AT (1) ATE346299T1 (de)
AU (1) AU3437700A (de)
CA (1) CA2366552A1 (de)
DE (1) DE60031963T2 (de)
ES (1) ES2276675T3 (de)
FR (1) FR2791140B1 (de)
WO (1) WO2000057185A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117056A1 (en) * 2009-06-18 2011-05-19 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
US20100167268A1 (en) * 2009-07-15 2010-07-01 Mikovits Judy A Seroconversion assays for detecting xenotropic murine leukemia virus-related virus
US20110151431A1 (en) * 2009-06-18 2011-06-23 Whittemore Peterson Institute For Neuro-Immune Disease Detection of xenotropic murine leukemia virus
WO2010148323A2 (en) * 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
EP2949342A1 (de) 2014-05-28 2015-12-02 Geneuro SA Antiretrovirales Arzneimittel zum Targeting des menschlichen endogenen Retrovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
US6340461B1 (en) * 1996-12-17 2002-01-22 David Stephen Terman Superantigen based methods and compositions for treatment of diseases
FR2765588A1 (fr) * 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques

Also Published As

Publication number Publication date
CA2366552A1 (fr) 2000-09-28
WO2000057185A1 (fr) 2000-09-28
ES2276675T3 (es) 2007-07-01
AU3437700A (en) 2000-10-09
DE60031963T2 (de) 2007-06-14
JP2002539804A (ja) 2002-11-26
FR2791140B1 (fr) 2002-03-22
EP1163522A1 (de) 2001-12-19
ATE346299T1 (de) 2006-12-15
US20060088820A1 (en) 2006-04-27
EP1163522B1 (de) 2006-11-22
FR2791140A1 (fr) 2000-09-22

Similar Documents

Publication Publication Date Title
GB9700012D0 (en) Improvements in the detection of bacteria
DK1389241T3 (da) Polynucleotid-sekventeringsfremgangsmåde
BR9507690A (pt) Detecção de reticulócitos
DE60029845D1 (de) System zum identifizieren der verhältnisse zwischen bestandteilen in aufgaben vom typ informations-wiederauffindung
AU6218201A (en) Detecting errors in the determination of magnetic location or orientation
DE59004587D1 (de) Messzelle für den elektrochemischen Gasnachweis.
ITTO20010411A0 (it) Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti.
BR9710836A (pt) Ensaio de analitos usando marcas em partìculas
AU1461702A (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
IL126826A0 (en) Optical hygrometers
AU9543698A (en) Method for detecting contamination and/or damage in a face running through a nipin a paper machine or in a paper finishing machine
DE60031963D1 (de) Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe
EP0911651A3 (de) Anordnung zur Kantbestimmung
ITTO990882A0 (it) Procedimento e dispositivo per la determinazione della concentrazione di eparina in un campione di fluido.
EA200200435A1 (ru) Анализ лептина
BR9803127A (pt) Aparelho e método para análise de fluido
DE3874605T2 (de) Mikrosonde in integrierter schalttechnik zur feststellung bestimmter gase.
DE60118918D1 (de) Prüfung von fingerabdrücken
EP1052511A4 (de) Verfahren zum testen der crohnschen krankheit und testkit dafür
BR9612475A (pt) Método de determinação do estado hepático de uma pessoa incluíndo um beneficiário para transplante de figado
FI101176B1 (fi) Mittauslaite ja menetelmä kohteiden mittaamiseksi
ATE439587T1 (de) Verwendung eines biologischen sensors zum nachweis von antibiotika
Powell et al. Using Life Cycle Inventory Analysis in the Development of a Waste Management Strategy for Gloucestershire, UK
BR9510669A (pt) Método para determinar ou detectar danos em órgão de doador em seguida ao xenotransplante com base em analitos derivados do órgão do doador
ES2184109T3 (es) Determinacion de analitos mediando utilizacion de dos marcaciones.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition